Fig. 5From: The CANVAS Program: implications of canagliflozin on reducing cardiovascular risk in patients with type 2 diabetes mellitus(Reprinted with permission from Rådholm [42])The CANVAS Program: a Hospitalization for HF and b CV death or hospitalization for HF. HF, heart failure; CV, cardiovascular; CI, confidence intervalBack to article page